GA-based CDMO picked up by private equity

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/pichet_w)
(Image: Getty/pichet_w)

Related tags: CDMO, Private equity, Manufacturing

The middle-market private equity firm Nautic Partners has acquired Mikart, an Atlanta, GA-headquartered contract development and manufacturing organization (CDMO).

Mikart, Inc. provides a range of services, including formulation development, clinical trial supplies, regulatory filing support, as well as clinical and commercial manufacturing, among others.

According to the company, ongoing investments in the business have included serialization-compliant packaging lines.

As part of the deal, Michael Kallelis will be joining the team at Mikart as the company’s new CEO.

Kallelis was most recently the vice president of business development at KMC Systems. He was also the chief operating officer and co-founder of the API contract manufacturing company Boston BioSystems, and has held senior roles at GE Life Sciences, Millipore, and Sepracor.

“In Nautic, Mikart has found the ideal partner to continue scaling the business while staying true to its customer-focused roots,”​ said Mikart’s retiring owner Miguel Arteche in a press release.

Kallelis added, “The work Miguel and Mikart’s management team have done to develop Mikart’s premier brand status in the market and strong reputation amongst customers is impressive. We hope to build off this foundation and partner with existing and future clients to fill their CDMO needs. ”

Related news

Show more

Related products

show more

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Related suppliers

Follow us


View more